NCT07790796

Brief Summary

The study will aim to evaluate the postoperative pain and bacterial load after application of two intracanal medications in mandibular first molar teeth with necrotic pulp. Methods (Participants, Interventions, and Outcomes) Study Setting: This randomized clinical trial will include 36 patients, equally allocated into three groups (12 patients each). Participants will be recruited from the Outpatient Clinic of the Endodontic Department, Faculty of Oral and Dental Medicine, Future University in Egypt. All treatments will be performed by a postgraduate master's degree candidate using a Ritter dental unit (Germany) and Sirona digital intraoral radiography (Nanopix, size 2). Eligibility Criteria: Eligible participants will be 18-40 years old with necrotic pulp and symptomatic apical periodontitis in restorable mandibular first molars (Type III mesial and distal canals) and willing to participate. Exclusion criteria include pregnancy, systemic diseases, recent use of analgesics or antibiotics, bruxism or clenching, severe traumatic malocclusion, and teeth with periapical radiolucency, root resorption, pulp stones/calcifications, or previous endodontic treatment.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
4mo left

Started Jan 2026

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Jan 2026Jan 2027

Study Start

First participant enrolled

January 6, 2026

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 21, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 27, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 6, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 6, 2027

Last Updated

August 27, 2026

Status Verified

January 1, 2026

Enrollment Period

1 year

First QC Date

August 21, 2026

Last Update Submit

August 25, 2026

Conditions

Keywords

Cocoa HuskCalcium hydroxideIntra-canal medication

Outcome Measures

Primary Outcomes (1)

  • postoperative pain

    6,12,24,48,and 72hours after root canal treatment by numerical rate scale (NRS)

Secondary Outcomes (1)

  • bacterial load reduction

    S1: after access cavity and before RCT. S2: after mechanical instrumentation S3: after intracanal medicament removal By Colony Forming Unit analysis18 CFU/ml (%)

Study Arms (3)

using calcim hydroxide as intra canal medication

ACTIVE COMPARATOR
Drug: Root canal treatment with intracanal medication by calcium hydroxide for one week.

cocoa husk as intra canal medication

EXPERIMENTAL
Drug: Root canal treatment with intracanal medication by cocoa husk for one week

cocoa husk mixed with calcium hydroxide as intra canal medication

EXPERIMENTAL
Drug: Root canal treatment with intracanal medication by calcium hydroxide with cocoa husk for one week.

Interventions

Following cleaning and shaping of the root canal, calcium hydroxide paste will be used as an intracanal medicament for one week to reduce bacterial load before the final root canal

using calcim hydroxide as intra canal medication

Root canal treatment with intracanal medication by cocoa husk for one week

cocoa husk as intra canal medication

Following cleaning and shaping, no intracanal medicament will be used. The root canal will be obturated according to the study protocol.

cocoa husk mixed with calcium hydroxide as intra canal medication

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may not qualify if:

  • \. Patients having bruxism or clenching 6. Patients have severe malocclusion associated with traumatic occlusion. 7. Teeth that have:
  • a. Peri-apical radiolucency b. Root resorption. c. Pulp stones or calcifications. d. Previous endodontic treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Future University

Cairo, Egypt

Location

MeSH Terms

Conditions

Dental Pulp NecrosisPain, Postoperative

Condition Hierarchy (Ancestors)

Dental Pulp DiseasesTooth DiseasesStomatognathic DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and SymptomsPostoperative ComplicationsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • fatouh

    future university

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Evaluation of post-operative pain and bacterial load reduction after application of three intra-canal medications (cocoa husk versus calcium hydroxide with and without cocoa) in necrotic mandibular first molar.

Study Record Dates

First Submitted

August 21, 2026

First Posted

August 27, 2026

Study Start

January 6, 2026

Primary Completion (Estimated)

January 6, 2027

Study Completion (Estimated)

January 6, 2027

Last Updated

August 27, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations